Latest News    

Seroba Announces Above Target Final Close of its Fund IV at €123M ($134M). • Seroba, a European life sciences venture capital firm headquartered in Dublin, with offices in Paris and Milan, announces the final close of […]

U.S.-Ireland Specialty Pharmaceutical Company’s ready-to-dilute form of a drug for the treatment of adenocarcinoma of the breast or ovary January 9, 2024 – CAMBRIDGE, Mass. – Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that […]

Naperville, Illinois, USA.   5 January, 2024.  Seroba’s portfolio company, Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced the submission of a Premarket Approval (PMA) […]

We use cookies and analytics to improve your online experience and to help us to understand where our audience is and how they reach us, as well as to understand what topics and site features are of greatest interest.  To find out more, please read our Privacy Policy. By clicking on the Accept button, you consent to our use of cookies and browsing analytics.

Scroll to Top